alter cell subpopul natur killer cell phenotyp patient progress system sclerosi scleroderma progress system sclerosi pss abnorm cell immunoregul present studi lymphocyt phenotyp patient pss normal control subject flow cytometri monoclon antibodi total suppressor helper helper-induc suppressor-induc human leukocyt antigen dr+b dr+t natur killer subset cell patient pss normal subject percentag similar sever patient rheumatoid arthriti t+dr+ cell patient pss late-limit gener diseas percentag percentag cell patient earli stage diseas result signific uniqu alter patient pss use stage diseas activ therapi defin immunolog defect 